Committees

Charter

The Industry Committee strives to:

• Be the global communication hub between therapeutic societies, regulatory policy makers, institutional stem cell centres and industry for the advancement of clinical investigation in cell therapy and regenerative medicine.
  
  

Projects & Objectives

• Drive industry/academic partnerships.
• Identify and develop reimbursement roadmaps and partner to influence coding and pricing decisions.
• Assist in developing partnerships and liaisons with appropriate clinical societies and/or sister societies.
• 2020 Commercialization Signature Series Meeting Report on Clinical Breakthroughs: Transforming the Standard of Care 
• 2019 Commercialization Signature Series Meeting Report on Patients First: Achieving Global CGT Adoption
• 2018 Commercialization Signature Series Meeting Report on Addressing Translational Manufacturing Viability in Cell Therapy
• The inaugural Commercialization Signature Series hosted on September 29, 2016.
  
  

The Committee

Chair

Anthony Ting, PhD

Kiji Therapeutics
United States

2024 Members

Elsa Abranches
AstraZeneca

Sasha Aleksic
FUJIFILM

Julie Allickson
Mayo Clinic

Caroline Blumer Toti
Miltenyi Biotec

Gregg Bodnar
NMDP

Dominic Clarke 
Discovery Life Sciences 

Vincenzo DiCerbo
ESP

Miguel Forte
Kiji Therapeutics

Maya Fuerstenau-Sharp
Sartorius Stedim Biotech GmbH

Cecilia Goldenberg
Dark Horse Consulting

John Hadden
Virocell Biologics

Matthew Hewitt
Charles River Laboratories

Shanya Jiang
ESP

Scott Jones
BioBridge Global

Sven Kili 
Sven Kili Consulting Ltd

Uma Lakshmipathy 
Thermo Fisher Scientific

Bruce Levine
University of Pennsylvania School of Medicine

Fernanda Masri
Cytomos

Aby J. Mathew
BioLife Solutions

Michael May
CCRM

Bill Milligan
Steminent Biotherapeutics

Jessica Pickrell
Terumo BCT

Patrick Rivers
Aquilo Capital

Beth San Segundo
OriGen Biomedical

Alberto Santagostino
Lonza

Antonio Scatena
Gateway Analytical

David Smith
Akron Biotech

Nathan Smith
Cell Therapies Pty Ltd

Jennifer Solomon
STEMCELL Technologies

Yoshie Tsurumaki
FIRM

Martin Westberg
Cytiva

Betty Woo
Thermo Fisher Scientific